Azithromycin for the Treatment of Obliterative Bronchiolitis after Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis
Authors:
Open Access
- 1 December 2016
- journal article
- review article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 22 (12) , 2264-2269
Abstract
No abstract availableKeywords
Funding Information
- National Center for Advancing Translational Sciences (UL1 TR000135)
- Mayo Clinic
This publication has 32 references indexed in Scilit:
- Relationship between FEV1 change and patient-reported outcomes in randomised trials of inhaled bronchodilators for stable COPD: a systematic reviewRespiratory Research, 2011
- Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trialsBMJ, 2011
- Constrictive Bronchiolitis in Soldiers Returning from Iraq and AfghanistanNew England Journal of Medicine, 2011
- Bronchiolitis Obliterans Syndrome Epidemiology after Allogeneic Hematopoietic Cell TransplantationTransplantation and Cellular Therapy, 2011
- Effects of Azithromycin in bronchiolitis obliterans syndrome after hematopoietic SCT—a randomized double-blinded placebo-controlled studyBone Marrow Transplantation, 2011
- Combined inhaled steroids and bronchodilatators in obstructive airway disease after allogeneic stem cell transplantationBone Marrow Transplantation, 2007
- Azithromycin in bronchiolitis obliterans complicating bone marrow transplantation: a preliminary studyEuropean Respiratory Journal, 2005
- Bronchiolitis obliterans in chronic graft-versus-host disease: analysis of risk factors and treatment outcomesTransplantation and Cellular Therapy, 2003
- Rapidly Progressive, Fixed Airway Obstructive Disease in Popcorn Workers: A New Occupational Pulmonary Illness?Journal of Occupational and Environmental Medicine, 2002
- Azithromycin Inhibits Quorum Sensing in Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 2001